ZA200500719B - The use of the combination of ciclesonide and antihitamines for the treatment of allergic rhinitis. - Google Patents

The use of the combination of ciclesonide and antihitamines for the treatment of allergic rhinitis.

Info

Publication number
ZA200500719B
ZA200500719B ZA200500719A ZA200500719A ZA200500719B ZA 200500719 B ZA200500719 B ZA 200500719B ZA 200500719 A ZA200500719 A ZA 200500719A ZA 200500719 A ZA200500719 A ZA 200500719A ZA 200500719 B ZA200500719 B ZA 200500719B
Authority
ZA
South Africa
Prior art keywords
ciclesonide
combination
antihitamines
treatment
allergic rhinitis
Prior art date
Application number
ZA200500719A
Other languages
English (en)
Inventor
Degenhard Marx
Helgert Mueller
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of ZA200500719B publication Critical patent/ZA200500719B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA200500719A 2002-08-30 2005-01-25 The use of the combination of ciclesonide and antihitamines for the treatment of allergic rhinitis. ZA200500719B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02019406 2002-08-30

Publications (1)

Publication Number Publication Date
ZA200500719B true ZA200500719B (en) 2006-02-22

Family

ID=31970274

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200500719A ZA200500719B (en) 2002-08-30 2005-01-25 The use of the combination of ciclesonide and antihitamines for the treatment of allergic rhinitis.

Country Status (21)

Country Link
US (2) US7879832B2 (de)
EP (2) EP2295062B1 (de)
JP (2) JP4746318B2 (de)
KR (1) KR101067795B1 (de)
CN (1) CN1674916A (de)
AT (1) ATE472329T1 (de)
AU (1) AU2003273396B2 (de)
BR (2) BRPI0313611B1 (de)
CA (1) CA2495830C (de)
DE (1) DE60333205D1 (de)
DK (1) DK1545548T3 (de)
ES (2) ES2393864T3 (de)
IL (1) IL166483A (de)
MX (1) MXPA05001885A (de)
NO (1) NO335400B1 (de)
NZ (1) NZ538954A (de)
PL (1) PL373433A1 (de)
PT (1) PT1545548E (de)
SI (1) SI1545548T1 (de)
WO (1) WO2004019955A1 (de)
ZA (1) ZA200500719B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
DE60323138D1 (de) * 2002-12-12 2008-10-02 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
JP2006527237A (ja) * 2003-06-13 2006-11-30 アルタナ　ファルマ　アクチエンゲゼルシャフト ホルモテロールと及びシクレソニドの組合せ物
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
EP2486942B1 (de) 2004-11-24 2018-10-10 Meda Pharmaceuticals Inc. Zusammensetzungen mit azelastin und anwendungsverfahren
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
WO2006097458A1 (en) * 2005-03-15 2006-09-21 Nycomed Gmbh Novel combination
US20080015241A1 (en) * 2006-07-13 2008-01-17 Cornerstone Biopharma, Inc. All day rhinitic condition treatment regimen
US20080311196A1 (en) * 2006-07-13 2008-12-18 White Donna F All Day Rhinitic Condition Treatment Regimen
JP5661985B2 (ja) * 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
KR100878698B1 (ko) * 2007-04-05 2009-01-13 한미약품 주식회사 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및이를 포함하는 약학 조성물
HUE026106T2 (en) * 2010-10-06 2016-05-30 Bausch & Lomb Bepotastine preparations
BR112013017183A2 (pt) * 2011-01-04 2017-07-25 Bausch & Lomb composições de bepostatina
BR112015023328A2 (pt) 2013-03-13 2017-07-18 Flatley Discovery Lab compostos de piridazinona e métodos para o tratamento de fibrose cística
CN106692115A (zh) * 2015-11-13 2017-05-24 天津金耀集团有限公司 一种环索奈德混悬鼻喷剂组合物

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (de) * 1963-04-24
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
US4369184A (en) * 1980-01-24 1983-01-18 Janssen Pharmaceutica N.V. 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
DE3877904D1 (de) * 1987-11-13 1993-03-11 Asta Pharma Ag Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
HU220868B1 (en) * 1993-04-02 2002-06-29 Byk Gulden Lomberg Chem Fab New prednisolone derivative, process for its production, use of the same and pharmaceutical composition containing the same
EP0709099A3 (de) 1994-09-28 1996-07-24 Senju Pharma Co Wässrige Suspension zur nasalen Verabreichung enthaltend Cyclodextrin
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
WO1997001341A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal mast cell stabilizers and topical nasal steroids
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
EP0780127A1 (de) 1995-12-19 1997-06-25 The Procter & Gamble Company Nasenspray enthaltend einen Steroid und einen Antihistamin
EP0954318A1 (de) 1996-06-04 1999-11-10 The Procter & Gamble Company Nasenspray enthaltend ein intranasales steroid und ein antihistamin
FR2754712B1 (fr) * 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
US20020111495A1 (en) * 1997-04-04 2002-08-15 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
CN1253508A (zh) 1997-04-30 2000-05-17 沃尼尔－朗伯公司 局部鼻用抗炎组合物
EP0903151A1 (de) 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Verwendung von Kombinationen enthaltend nichtsedierende Antihistaminika und Alfa-Adrenergische Agonisten für die topische Behandlung von Rhinitis/Konjunktivitis sowie Erkältungs- und Grippe-Symptomen
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6297227B1 (en) * 1998-09-10 2001-10-02 Schering Corporation Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
DE19947234A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
WO2001028517A1 (fr) 1999-10-20 2001-04-26 Teijin Limited Compositions therapeutiques aqueuses
US20040097486A1 (en) * 1999-11-18 2004-05-20 Yanni John M. Use of an H1 antagonist and a safe steroid to treat eye conditions
AU772406B2 (en) 1999-11-18 2004-04-29 Alcon Inc. Use of H1 antagonist and a safe steroid to treat eye conditions
US6653313B2 (en) 2000-08-10 2003-11-25 Warner-Lambert Company Llc 1,4-dihydropyridine compounds as bradykinin antagonists
US6706726B2 (en) * 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
BR0214643A (pt) 2001-12-05 2004-11-03 Alcon Inc Aplicação de um antagonista h1, e um esteróide seguro para tratar rinite
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
JP2006508138A (ja) * 2002-11-12 2006-03-09 アルコン，インコーポレイテッド アレルギー性鼻炎を処置するための抗アレルギー剤およびステロイドの使用

Also Published As

Publication number Publication date
MXPA05001885A (es) 2005-06-03
ATE472329T1 (de) 2010-07-15
CA2495830A1 (en) 2004-03-11
KR20050058400A (ko) 2005-06-16
IL166483A (en) 2013-11-28
EP2295062A1 (de) 2011-03-16
DK1545548T3 (da) 2010-09-27
EP1545548A1 (de) 2005-06-29
JP2011021043A (ja) 2011-02-03
CA2495830C (en) 2012-08-21
CN1674916A (zh) 2005-09-28
US20050245493A1 (en) 2005-11-03
SI1545548T1 (sl) 2010-11-30
IL166483A0 (en) 2006-01-15
BRPI0313611B1 (pt) 2018-03-06
US8486923B2 (en) 2013-07-16
KR101067795B1 (ko) 2011-09-27
AU2003273396B2 (en) 2008-12-11
US7879832B2 (en) 2011-02-01
NO20051521L (no) 2005-03-22
ES2393864T3 (es) 2012-12-28
JP4746318B2 (ja) 2011-08-10
DE60333205D1 (de) 2010-08-12
NZ538954A (en) 2007-04-27
EP2295062B1 (de) 2012-08-29
BR0313611A (pt) 2005-06-21
NO20051521D0 (no) 2005-03-22
AU2003273396A1 (en) 2004-03-19
US20110092471A1 (en) 2011-04-21
EP1545548B1 (de) 2010-06-30
JP2005539044A (ja) 2005-12-22
PL373433A1 (en) 2005-08-22
PT1545548E (pt) 2010-09-02
NO335400B1 (no) 2014-12-08
ES2348034T3 (es) 2010-11-29
WO2004019955A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
ZA200500719B (en) The use of the combination of ciclesonide and antihitamines for the treatment of allergic rhinitis.
EP1490044A4 (de) Kombinationstherapie zur behandlung von zuständen mit pathogenen entzündlichen komponenten
IL176393A (en) Patterned laser treatment of the retina
EE05417B1 (et) Epotilooni analoogide ja kemoterapeutikumide kombinatsiooni kasutamine teraapias
HK1092367A1 (en) Combination therapy for the treatment of ocular neovascular disorders
DE60229922D1 (de) Kombinationen, ein antidiarrhoikum und epothilon oder ein epothilonderivat enthaltend
PL366636A1 (en) Pyranoindazoles and their use for the treatment of glaucoma
EP1543034A4 (de) Behandlung und prophylaxe mit 4-1bb-bindenden mitteln
PL375964A1 (en) Use of indolyl derivatives for the manufacture of a medicament for the treatment allergic rhinitis
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
HK1083767A1 (en) Combined use of a fibrate and orlistat for the treatment of obesity
ATE491442T1 (de) 1-phenyl-2- dimethylaminomethylcyclohexanverbindungen zur therapie von depressiven symptomatiken, schmerz und inkontinenz
EP1455780A4 (de) Neue benzodifuranimidazolin- und benzofuranimidazolin-derivate und ihre verwendung zur behandlung von glaukom
HUP0300990D0 (en) Synergistic combination for the prophylaxis and treatment of diabetes
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
TNSN05154A1 (en) Use of levocetirizine for the treatment of persistent allergic rhinitis
IL164951A0 (en) The treatment of pain with lfendropil
DE60304678D1 (de) Idraparinux (sanorg 34006) zur behandlung und sekundärprophylaxe von thromboembolien bei patienten mit tiefer venenthrombose
AUPS255402A0 (en) Agents and methods for the treatment of disorders associated with oxidative stress
NO20033160D0 (no) Anordning for behandling av gravann
GB0216220D0 (en) The treatment of emesis nausea and other disorders
GB0213870D0 (en) The treatment of pain conditions